Chembond Q1 revenue up 25% to ₹72.4 cr, net profit jumps 43%
Standard quarterly update shows continued momentum in specialty chemicals and animal health; routine disclosure for a nano-cap.
What's new
- Consolidated revenue ₹72.4 crore, up 25% YoY.
- Net profit attributable to shareholders ₹5.7 crore, up 43%.
- Standalone revenue ₹63 crore, PAT ₹4.5 crore.
Why this matters
The results confirm healthy demand in specialty chemicals and animal health. But for a nano-cap with a market cap of ₹247 crore, a routine quarterly filing rarely surprises. The clean balance sheet (debt/equity 0.02) and ROE of 11.3% are positives, yet a P/E of 19.2 leaves little margin for error.
What we're watching
- Whether growth sustains in the coming quarters.
- Any management commentary on input cost trends.
- New order wins in the specialty chemicals segment.
The full read
Chembond Material Technologies delivered a solid Q1. Consolidated revenue rose 25% year-on-year to ₹72.4 crore, while net profit jumped 43% to ₹5.7 crore. Standalone numbers were also healthy: revenue of ₹63 crore and PAT of ₹4.5 crore. The growth is driven by the specialty chemicals and animal health segments. That's the good news. The reality check: this is a routine quarterly filing — the market knew the board meeting was coming. For a nano-cap with a market cap of ₹247 crore, such updates are rarely market-moving. The balance sheet is pristine (debt/equity 0.02) and ROE stands at 11.3%, but the P/E of 19.2x leaves little room for upside unless growth accelerates. Investors should wait for management commentary to judge sustainability.
Questions answered
- How does this quarter compare to the previous quarter?
- The filing only provides year-over-year comparisons. The revenue of ₹72.4 crore is 25% higher than the year-earlier quarter's ₹57.9 crore (calculated).
- What drove the revenue growth?
- The company attributes growth to its specialty chemicals and animal health business segments.
- Why is this considered a routine filing?
- Quarterly results are standard periodic disclosures required under listing regulations. The market had prior notice of the board meeting, and such announcements rarely contain unanticipated price-sensitive information for a nano-cap company.
- What are the standalone numbers?
- Standalone revenue for the quarter was ₹63 crore and profit after tax was ₹4.5 crore.
- What is the company's debt level?
- The debt-to-equity ratio is very low at 0.02, indicating minimal leverage.
- Is the stock overvalued at current levels?
- With a trailing P/E of 19.2 and ROE of 11.3%, the valuation appears fair but not cheap for a nano-cap in a cyclical sector.